Results
1 -
10 of
1706
(Click
here to explore results)
- An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma. Stefano Tartaggia, Anna Meneghello, Ottavia Bellotto, Ariana Soledad Poetto, Martina Zanchetta, Bianca Posocco, David Bunka, Federico Polo, Giuseppe Toffoli
, Analyst
, 2021
, 146
, 1714
- Performance of solvent resistant nanofiltration membranes for purification of residual solvent in the pharmaceutical industry: experiments and simulation. Siavash Darvishmanesh, Loghman Firoozpour, Johan Vanneste, Patricia Luis, Jan Degrève, Bart Van der Bruggen
, Green Chem.
, 2011
, 13
, 3476
- Chitosan grafted onto Fe3O4@poly(N-vinylcaprolactam) as a new sorbent for detecting Imatinib mesylate in biosamples using UPLC-MS/MS. Hamed Sahebi, Seied Mahdi Pourmortazavi, Hamed Zandavar, Somayeh Mirsadeghi
, Analyst
, 2019
, 144
, 7336
- Sustained anti-BCR-ABL activity with pH responsive imatinib mesylate loaded PCL nanoparticles in CML cells. Barbara Cortese, Stefania D'Amone, Giuseppe Gigli, Ilaria Elena Palamà
, Med. Chem. Commun.
, 2015
, 6
, 212
- Bioengineering approaches to study multidrug resistance in tumor cells. Brian Fallica, Guy Makin, Muhammad H. Zaman
, Integr. Biol.
, 2011
, 3
, 529
- The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib. Benjamin J. Deadman, Mark D. Hopkin, Ian R. Baxendale, Steven V. Ley
, Org. Biomol. Chem.
, 2013
, 11
, 1766
- Differential interactions of imatinib mesylate with the membrane skeletal protein spectrin and hemoglobin. Debashree Das, Ushasi Pramanik, Malay Patra, Mousumi Banerjee, Abhijit Chakrabarti
, RSC Adv.
, 2016
, 6
, 55203
- Investigations regarding the utility of prodigiosenes to treat leukemia. Deborah A. Smithen, A. Michael Forrester, Dale P. Corkery, Graham Dellaire, Julie Colpitts, Sherri A. McFarland, Jason N. Berman, Alison Thompson
, Org. Biomol. Chem.
, 2013
, 11
, 62
- Coupled delivery of imatinib mesylate and doxorubicin with nanoscaled polymeric vectors for a sustained downregulation of BCR-ABL in chronic myeloid leukemia. Ilaria E. Palamà, Barbara Cortese, Stefania D'Amone, Valentina Arcadio, Giuseppe Gigli
, Biomater. Sci.
, 2015
, 3
, 361
- Simultaneous quantification of imatinib and CGP74588 in human plasma by liquid chromatography-time of flight mass spectrometry (LC-TOF-MS). S. J. Kumari A. Ubhayasekera, Warunika Aluthgedara, Bo Ek, Jonas Bergquist
, Anal. Methods
, 2016
, 8
, 3046